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CARDIOTHORACIC TRANSPLANTATIONWho is the high-risk recipient? Predicting mortality after lung
transplantation using pretransplant risk factors
Mark J. Russo, MD, MS,a,b Ryan R. Davies, MD,a Kimberly N. Hong, MHSA,b Alexander Iribarne, MD,a,b
Steven Kawut, MD,c Matthew Bacchetta, MD,a Frank D’Ovidio, MD, PhD,a Selim Arcasoy, MD,c and
Joshua R. Sonett, MDa
Objectives: The purpose of this study was to create a preoperative risk stratification score (RSS) based on pre-
transplant recipient characteristics that could be used to predict mortality following lung transplantation.
Methods: United Network for Organ Sharing provided deidentified patient-level data. The study population in-
cluded 8780 adult recipients (age>12 years) having lung transplantation from January 1, 1999, to December 31,
2006. Multivariate logistic regression (backward, P>.10) was performed. Using the odds ratio for each identified
variable, an RSS was devised. The RSS included only pretransplant recipient variables and excluded donor
variables.
Results: The strongest negative predictors of 1-year survival included extracorporeal membrane oxygenation,
decreased estimated glomerular filtration rate, total bilirubin>2.0 mg/dL, recipient age, hospitalization at time
of transplant, O2 dependence, cardiac index<2, steroid dependence, donor:recipient weight ratio<0.7, all
non–cystic fibrosis/chronic obstructive pulmonary disease etiologies, and female donor–to–male recipient.
Threshold analysis identified 4 discrete groups: low risk, moderate, elevated risk, and high risk. The 1-year
actuarial survival was 80.4% for the entire group, compared with 56.8% in the high-risk group (RSS> 7.2,
n ¼ 490; 6%).
Conclusion: Pretransplant recipient variables significantly influence both early and late survival following lung
transplantation. Some patients face a higher than average risk of mortality during their first year posttransplant,
which challenges the goals of equitable organ allocation. RSS may improve organ allocation strategies by avoiding
the potential negative impact of performing transplantation in extremely high-risk candidates.Supplemental material is available online.
Lung transplantation offers substantial benefits to patients
with end-stage lung disease.1-3 Unfortunately, as organs
available for transplant remain critically scarce, achieving
maximal benefit from transplantation is predicated on im-
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fits associated with performing transplantation in various
groups of lung transplant candidates must be better under-
stood.
The purpose of this study is to risk stratify lung transplant
candidates based on pretransplant recipient characteristics.
Specifically, this analysis used objective methods to identify
pretransplant recipient characteristics associated with post-
transplant survival at 1 year. Based on these factors, a risk
stratification score (RSS) was developed to predict 1-year
mortality following lung transplantation in adolescents and
adult recipients.
METHODS
Data Collection
Use of these data is consistent with the regulations of our university’s
Institutional Review Board and the United Network for Organ Sharing
(UNOS)’s Data Use Agreement. The Standard Transplant Analysis and Re-
search Dataset were provided by UNOS (data source #033108-3).
Study Population
All recipients aged 12 years and older having lung transplantation be-
tween January 1, 1999, and December 31, 2006, were included in the study
population. Patients were excluded if they had other simultaneous organ
transplantation (n ¼ 17). Follow-up data were provided through February
8, 2008. Patients were followed from the date of transplant until death, re-
transplantation, or date of last known follow-up, which was the last day of
follow-up data provided by UNOS.urgery c November 2009
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ALT ¼ alternate list transplant
BMI ¼ body mass index
ECMO ¼ extracorporeal membrane oxygenation
LAS ¼ lung allocation score
OR ¼ odds ratio
ROC ¼ receiver operating characteristic
RSS ¼ risk stratification score
SSLR ¼ stratum-specific likelihood ratio
UNOS ¼ United Network for Organ Sharing
Outcome Measures
The primary outcome measure was 1-year mortality. In survival analysis,
the outcome of interest was death (n¼ 3420, 39%). Patients lost to follow-
up (n ¼ 102, 1%), those who had retransplantations (n ¼ 210, 2%), and
those alive at last known follow-up (n ¼ 5014, 57%) were censored at
the date of last known follow-up.
Data Analysis
All data were analyzed using a statistical software package, Stata 9 (Stata
Corp, College Station, Tex). Continuous variables are reported as means 
standard deviation and compared using the Student t test. To compare cat-
egorical variables, the chi-square test was used. Kaplan-Meier analysis with
log-rank test was used for time to event analysis. All reported P values are
2-sided.
Logistic regression was used to develop a model to predict 1-year mor-
tality to assess the simultaneous effect of multiple variables on survival fol-
lowing lung transplant. Variables included in the model are summarized in
Table 1. All variables significant in univariate analysis were included in the
regression, and backward selection (P< .10) was used to construct the
models. The odds ratio (OR) and 95% confidence interval are reported
for each factor. Using the OR calculated in regression analysis, weights
were assigned for each risk factor. Model discrimination between survivors
and nonsurvivors was assessed by calculating the area under the receiver op-
erating characteristic (ROC) curve.
Patients’ risk strata were calculated using threshold analysis with ROC
curves and stratum-specific likelihood ratios (SSLR). ROC curves were
generated by plotting sensitivity on the ordinate and 1 specificity on the
abscissa with RSS as a continuous variable and 1-year mortality as a binary
outcome.5 SSLRs and 95% confidence intervals were generated using
threshold values at regular intervals as previously described.6,7 Threshold
values were determined by combining adjacent volume strata with other sta-
tistically indistinct strata based on the presence of SSLRs with overlapping
95% confidence intervals. Threshold values occurred when 2 statistically
distinct strata could be formed. This process was repeated until no additional
threshold values were found.
RESULTS
Study Population
Analysis included 8780 lung transplant recipients with
22,452.1 person-years at risk and 2.56  2.12 mean fol-
low-up years. Due to missing data, 1007 (11%) were ex-
cluded from logistic regression.
Risk Factors
The logistic regression model of postoperative mortality
is shown in Table 1. The model had good ability to discrim-The Journal of Thoracic and Cinate between survivors and nonsurvivors with an area under
the receiver operator characteristic curve of 0.67 (0.64–
0.69).
Risk Groups
Threshold analysis identified 4 discrete groups (Table 2):
low risk, moderate, elevated risk, and high risk. Patients with
scores>7.2 were in the high-risk group (n ¼ 490; 6%). No
single high-risk characteristic was sufficient to place recipi-
ents in the high-risk group, and nearly 93% of recipients in
the high-risk group contained 5 to 7 risk factors. This pattern
of stacked risk factors persisted in the elevated-risk group,
with 69% of this group having 5 to 7 high-risk characteris-
tics. In contrast, the majority of recipients in the low-risk
(99.8%) and moderate-risk (77.4%) groups had between
0 and 4 risk factors. The high-risk group had a 1-year actu-
arial survival of 57% and a median survival of 1.97 years.
Survival functions and statistics can be found in Figure 1
and Table 2.
DISCUSSION
The importance of patient selection in lung transplanta-
tion is supported both by clinical observation as well as ob-
jective data.4,8 This analysis provides further evidence that it
is possible to risk stratify lung transplant candidates based
on pretransplant characteristics.
High-Risk Recipient Characteristics
No single risk factor was sufficient to place a recipient in
the highest risk category. However, the strongest negative
predictor of 1-year mortality was extracorporeal membrane
oxygenation (ECMO) dependence, with only 44% alive at
1 year. ECMO and hospitalized at transplant, which all
ECMO patients were, was sufficient to place recipients in
the highest category; therefore, all ECMO-dependent
candidates (n ¼ 34) were in the high-risk group. While it
is possible that in the future ECMO will be offered to less
morbid patients given newer cannula configurations and
the potential for ‘‘walking’’ ECMO, during the study period
recipients on ECMO had, on average, 5.7 risk factors.
Other strong predictors included retransplantation, poor
renal function, poor liver function, and advanced-age
recipients. The majority of recipients in the high-risk group
had between 5 and 7 risk factors. This supports the concepts
that stacking risk factors presages poor outcome.
How Do High-Risk Patients Fare?
When comparing the high-risk group with the other
groups, the risk of death in the first year posttransplant
was 2- to 3-fold higher. Furthermore, long-term survival
was significantly diminished, with median survival of the
high-risk group approximately one-third of the low-risk
and moderate-risk groups. For the high-risk group, trans-
plantation has limited clinical effectiveness. This findingardiovascular Surgery c Volume 138, Number 5 1235
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Points OR 95% CI P value
Risk score variables
ECMO 6.9 6.937 2.391–20.127 .000
Recipient eGFR (mL/min)<33 2.3 2.269 1.431–3.598 .000
Recipient age (y)  70 2.3 2.261 1.163–4.395 .016
Total bilirubin>2.0 mg/dL 2.2 2.172 1.653–2.852 .000
O2 requiring  5 L 2.1 2.071 1.583–2.709 .000
Etiology retransplantation 2.1 2.055 1.413–2.989 .000
Etiology sarcoidosis 1.9 1.905 1.357–2.674 .000
Etiology A1A deficiency 1.9 1.864 1.421–2.444 .000
Hospitalized at the time
of transplant
1.8 1.837 1.483–2.277 .000
O2 requiring 1–4 L 1.7 1.685 1.353–2.099 .000
Etiology pulmonary hypertension 1.7 1.677 1.166–2.412 .005
Recipient age (y): 55–70 1.4 1.373 1.194–1.579 .000
Cardiac index<2 1.4 1.363 1.074–1.731 .011
Etiology pulmonary fibrosis 1.3 1.326 1.120–1.569 .001
Requiring steroids 1.3 1.325 1.155–1.521 .000
Donor:recipient weight
ratio<0.7
1.3 1.292 1.024–1.630 .031
Etiology: other 1.3 1.266 0.967–1.657 .086
Female donor
to male recipient
1.2 1.213 1.001–1.470 .049
Other variables
BMI<18.5 (underweight) 1.188 0.952–1.482 .128
BMI 25–29.99 (overweight) 1.092 0.928–1.286 .290
BMI 30–34.99 (obese) 1.065 0.849–1.337 .585
Center volume 0.998 0.998–0.999 <.001
Clinical evidence
of infection
0.965 0.831–1.120 .637
Diabetes (recipient)  6 y 1.682 0.732–3.868 .221
Diabetes (recipient) 0–5 y 1.312 0.800–2.151 .282
Diabetes complicated by CVA 1.743 0.273–11.144 .557
Diabetes complicated by PVD 0.725 0.148–3.559 .692
Diabetes complicated by renal
failure (eGFR<40 mL/min)
0.718 0.205–2.515 .604
Dialysis dependent 0.819 0.242–2.773 .748
Donor age 1.001 0.995–1.008 .643
Donor drug use in the last 6 mo 0.872 0.642–1.184 .379
Donor eGFR (mL/min) 0.999 0.992–1.007 .850
Donor history of cancer 0.673 0.373–1.215 .189
Donor insulin dependence 1.073 0.588–1.955 .819
Etiology cystic fibrosis 1.035 0.729–1.471 .847
Female donor
to female recipient
1.004 0.842–1.198 .964
FEV1:FVC ratio 0.866 0.638–1.175 .355
Hepatitis Cþdonor 4.890 1.805–13.251 .002
Hepatitis Cþ recipient 1.119 0.681–1.840 .658
HLM mismatch  3 1.080 0.884–1.320 .452
Hypertension  6 y 1.031 0.645–1.650 .898
Hypertension 0–5 y 1.174 0.936–1.474 .166
Infection within 2 wk of
transplant
1.112 0.863–1.434 .412
Inotropic support at the time
of transplant
1.236 0.908–1.682 .178
Intubated at the time of transplant 1.135 0.744–1.732 .5581236 The Journal of Thoracic and Cardiovascular Sraises concerns regarding the appropriateness of allocating
organs to such high-risk patients.
Lung Allocation Score
In May 2005, the Organ Procurement and Transplantation
Network implemented the lung allocation score (LAS). With
subsequent increases in the number of transplants, decreases
in wait time, and reductions in deaths on the waiting list,9
LAS has been a significant advance from the previous allo-
cation system, which was based strictly on waiting list time.
However, LAS is more heavily weighted toward the risk of
mortality on the waiting list than risk of posttransplant mor-
tality6—not surprisingly, LAS is inversely related to short-
term survival (Appendix 1). Therefore, given the findings
that LAS is also associated with higher rates of primary graft
dysfunction and longer intensive care unit lengths of stay,9
there remains concern that an increasing number of critically
ill candidates with an unacceptably high risk of poor out-
come will be transplanted.10 In fact, over the duration of
this study, the percentage of recipients falling within the
low-risk category decreased from 42.4% in 1999 to
32.7% in 2006; concurrently the percentage of recipients
categorized as high risk by the RSS increased from 4.9%
in 1999 to 8.6% in 2006 (Appendix 2).
Implications for Recipient Selection and Organ
Allocation
In an effort to limit allocation of scarce organs to candi-
dates with a high likelihood of poor posttransplant outcome,
it may be prudent to incorporate a safeguard in the current
allocation system. Such a system could utilize an RSS,
such as presented here, to estimate a candidate’s posttrans-
plant risk. Candidates with a risk exceeding a predetermined
threshold would have their LASs significantly reduced or be
inactivated.
A second possibility is to implement an alternate list trans-
plant (ALT) strategy, a strategy used by a number of heart
TABLE 1. Continued
Points OR 95% CI P value
Ischemic time (h) 1.045 1.002–1.090 .042
Male donor
to female recipient
1.018 0.831–1.246 .867
Prostaglandin at the time
of transplant
0.924 0.296–2.886 .892
Recipient age (y) 18–39 1.453 0.961–2.197 .077
Recipient age (y) 40–55 1.398 0.900–2.171 .136
Recipient eGFR (mL/min) 33–53 1.224 0.912–1.643 .179
Six-min walk<150 ft 1.056 0.842–1.324 .639
Transplant year 0.880 0.932–0.000 .906
Treated for resistant infection 1.067 0.653–1.745 .794
BMI, Body mass index; CI, confidence interval; CVA, cerebral vascular accident;
ECMO, extracorporeal membrane oxygenation; eGFR, estimated glomerular filtration
rate;FEV1, forced expiratory volume in 1 second; FVC, forced vital capacity;OR, odds
ratio; PVD, peripheral vascular disease.urgery c November 2009
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eligible for organs if the organ is not suitable for any poten-
tial standard recipient.11 As donor organs utilized by ALT
recipients would often otherwise be discarded, this strategy
may expand the use of potential donor organs. Conversely,
these lower-quality donor organs would likely be associated
with further diminished outcomes. Considering the signifi-
cant potential benefits and risks, outcomes, including
survival, quality of life, and cost-effectiveness, recipients
would have to be closely monitored to determine the viabil-
ity of such a strategy.
A third possibility would be to refer high-risk candidates
to high-volume centers. Multivariate regression demon-
strated that increased center volume is associated with supe-
rior survival at 1 year. In this analysis, high-risk candidates
had a 50.0% 1-year survival at centers that transplant fewer
than 10 recipients per year compared with 66.7% 1-year
survival at centers transplanting more than 20 recipients
annually.
Finally, regardless of how risk stratification is used to
improve organ allocation, the RSS may have additional
benefits. With increasing quality oversight and variable re-
imbursement schemes based on performance, introduction
of a risk stratification schema may improve quality mea-
sures and reimbursement by better accounting for case
mix at centers that might otherwise be penalized on these
measures for providing care to greater number high-risk
transplants.
Future Studies
Additional studies are needed to validate the model pre-
sented in this analysis. Furthermore, future studies should
consider quality of life and cost implications of transplanting
various groups of lung transplant candidates. Finally, future
studies should include subanalyses that consider combina-
tions of recipient and donor factors.
TABLE 2. Risk group strata thresholds and outcomes
Low
risk
Moderate
risk
Elevated
risk
High
risk Total
n 3055 3411 800 490 7756
% 39.4 44.0 10.3 6.3
Score <3.50 3.50–5.80 5.90–7.20 >7.20 5.0
SSLR 0.61 1.03 1.55 3.20
LL SSLR 0.56 0.96 1.34 2.70
UL SSLR 0.67 1.09 1.80 3.79
Actuarial 1-y survival (%) 87.1 80.4 73.1 56.8 80.4
Median survival (y) 5.45 4.41 3.80 1.97 4.70
Number of risk
factors (%)
0–4 99.8 77.4 30.9 5.2 77.6
5–7 0.2 22.6 69.1 92.5 22.3
 8 0.0 0.0 0.0 2.4 0.1
SSLR, Stratum-specific likelihood ratio; LL, lower limit; UL, upper limit.The Journal of Thoracic and CLimitations
These data have several limitations. First, patient regis-
tries often suffer from variability in data entry. However,
fields contained within this database were generally well
populated with a 95% to 99% data entry rate for the major-
ity of variables. Though the UNOS reporting system
provided definitions for variables in data guidelines, defini-
tions may vary by center. Second, although the data analysis
supports associations between variables and outcomes,
causal relationships cannot be determined. Many of the
risk factors may simply be markers for poor clinical status
before transplantation rather than direct causal factors in
poor survival. Third, for the purpose of simplifying the scor-
ing mechanism, continuous variables, such as recipient age,
estimated glomerular filtration rate, and body mass index
(BMI) were converted to discrete categories. An attempt
was made to divide variables by logical or clinical relevant
means. For example, recipients were grouped into discrete
BMI categories based on the Expert Panel on the Identifica-
tion, Evaluation, and Treatment Overweight and Obesity in
Adults’ BMI classification scheme. This strategy, however,
decreases the power of the model. Furthermore, it suggests
that recipients with similar BMIs (e.g., 34.9 and 35.1 kg/m2)
may fall into different risk categories even though it is
unlikely that they face significantly different risks based
on BMI alone. If applied on a broader scale, a more sophis-
ticated score, using equations that allow for continuous
variables, could be assigned. Finally, the RSS remains to
be validated, and further studies are required to confirm its
accuracy in predicting early posttransplant outcomes. In
this analysis, the study population includes patients trans-
planted from 1999 to 2006. As demonstrated in the multivar-
iate regression analysis, year of transplant had a significant
impact on survival. Therefore, to ensure that this score is
relevant to the current population of recipients, this model
should be validated using the most up-to-date data
FIGURE 1. Legend. Survival function by risk strata. LR, Low-risk; IR,
intermediate-risk; ER, elevated-risk; HR, high-risk.ardiovascular Surgery c Volume 138, Number 5 1237
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LAS, would likely need to be revised due to temporal
changes in the composition of the recipients and new thera-
peutic adjuncts used in their care.
CONCLUSION
Pretransplant recipient variables significantly influence
early and late survival following lung transplantation, suggest-
ing that some patients face a higher than average risk of mor-
tality during the first year posttransplant, as well as severely
diminished longer-term survival, that challenges the goals of
equitable organs allocation. RSS may improve organs alloca-
tion strategies by avoiding the potential poor outcomes associ-
ated with transplanting extremely high-risk candidates.
We thank UNOS for supplying these data and Katarina
Anderson, PhD, for her assistance with our analysis.
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LAS
90-d survival,
n (%)*
1-y survival,
n (%)*
<40 28 (82.1) 24 (88.9)
40–49 1520 (85.9) 1258 (92.6)
50–59 474 (84.6) 379 (89.2)
60–69 125 (80.8) 93 (88.6)
70–79 65 (78.5) 47 (82.5)
>80 122 (69.7) 86 (78.2)
LAS, Lung allocation score. *P< .001.T
XAPPENDIX 2. Percentage of recipients by risk group and transplant year
Year n Low risk* Moderate risk Elevated risk High risk*
1999 736 42.4 43.6 9.1 4.9
2000 788 43.9 43.8 7.6 4.7
2001 860 44.0 42.0 9.2 4.9
2002 870 38.7 44.8 10.8 5.6
2003 948 40.5 45.3 9.1 5.2
2004 1033 41.0 43.2 10.0 5.9
2005 1267 36.7 44.8 10.0 8.5
2006 1254 32.7 44.0 14.7 8.6
*P< .001.The Journal of Thoracic and Cardiovascular Surgery c Volume 138, Number 5 1238.e1
